Generic Name: coagulation factor VIIa (injection) (koe AG yoo LAY shun FAK tor)
Brand Names: NovoSeven, NovoSeven RT
What is coagulation factor VIIa?
Coagulation factor VIIa is a man-made protein that is similar to a natural protein in the body that helps the blood to clot.
Coagulation factor VIIa is used to treat or prevent bleeding in people with hemophilia A or hemophilia B, or factor VII deficiency.
Coagulation factor VIIa may also be used for other purposes not listed in this medication guide.
What is the most important information I should know about coagulation factor VIIa?
Before using this medication, tell your doctor if you are allergic to any drugs, or if you have coronary artery disease (hardening of the arteries), a history of stroke or heart attack, a severe injury or infection, or if you are allergic to mouse, hamster, or pork proteins.
To be sure this medication is helping your condition, your blood will need to be tested on a regular basis. Do not miss any scheduled visits to your doctor.
Carry an ID card or wear a medical alert bracelet stating that you have a bleeding disorder in case of emergency. Any doctor, dentist, or emergency medical care provider who treats you should know about your condition.
What should I discuss with my healthcare provider before using coagulation factor VIIa?
If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using coagulation factor VIIa, tell your doctor if you have:
coronary artery disease (hardening of the arteries);
a history of stroke or heart attack;
a severe injury or infection; or
if you are allergic to mouse, hamster, or pork proteins.
FDA pregnancy category C. Coagulation factor VIIa may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether coagulation factor VIIa passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I use coagulation factor VIIa?
Coagulation factor VIIa is given as an injection through a needle placed into a vein. Your doctor, nurse, or other healthcare provider will give you this injection. You may be shown how to use your medicine at home. Do not self-inject this medicine if you do not fully understand how to give the injection and properly dispose of needles, IV tubing, and other items used in giving the medicine.
You may need to mix coagulation factor VIIa with a liquid (diluent) before using it. If you are using the injections at home, be sure you understand how to properly mix and store the medication. Do not use the medication if it has changed colors or has any particles in it. Call your doctor for a new prescription.
To be sure this medication is helping your condition, your blood will need to be tested on a regular basis. Do not miss any scheduled visits to your doctor.
Carry an ID card or wear a medical alert bracelet stating that you have a bleeding disorder in case of emergency. Any doctor, dentist, or emergency medical care provider who treats you should know about your condition. NovoSeven should be stored in the refrigerator. Do not freeze. Avoid exposing the medication to sunlight. NovoSeven RT may be stored at cool room temperature away from moisture, heat, and light.
After mixing NovoSeven RT with a diluent, you may keep it at room temperature or in the refrigerator and use it within 3 hours. Do not freeze or store the mixture in a syringe.
What happens if I miss a dose?
Contact your doctor if you miss a dose of this medication.
What happens if I overdose?
Seek emergency medical attention if you think you have used too much of this medicine.
An overdose of coagulation factor VIIa is not expected to produce life-threatening symptoms.
What should I avoid while using coagulation factor VIIa?
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using this medication.
Coagulation factor VIIa side effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:
fever;
any bleeding that will not stop;
feeling like you might pass out;
urinating less than usual or not at all;
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or balance; or
pain or swelling in one or both legs.
Less serious side effects may include:
headache;
joint pain;
nausea, vomiting;
swelling;
mild itching or rash; or
pain, redness, swelling, or irritation where the medicine was injected.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Coagulation factor VIIa Dosing Information
Usual Adult Dose for Hemophilia A:
Treatment of bleeding episodes in hemophilia A or B with inhibitors:
90 micrograms/kg by intravenous bolus injection every 2 hours until hemostasis is achieved. Post-hemostatic dosing every 3 to 6 hours for severe bleeds.
Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B with inhibitors:
90 micrograms/kg by intravenous injection immediately before surgery and every 2 hours during surgery. Post-surgical dosing: For minor procedures, dosing every 2 hours for 48 hours and then every 2 to 6 hours, and for major procedures every 2 hours for the first 5 days and then every 4 hours, until healing has occurred.
Acquired hemophilia - bleeding episodes or surgery:
70 to 90 micrograms/kg by intravenous bolus injection every 2 to 3 hours until hemostasis is achieved.
Usual Adult Dose for Hemophilia B:
Treatment of bleeding episodes in hemophilia A or B with inhibitors:
90 micrograms/kg by intravenous bolus injection every 2 hours until hemostasis is achieved. Post-hemostatic dosing every 3 to 6 hours for severe bleeds.
Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B with inhibitors:
90 micrograms/kg by intravenous injection immediately before surgery and every 2 hours during surgery. Post-surgical dosing: For minor procedures, dosing every 2 hours for 48 hours and then every 2 to 6 hours, and for major procedures every 2 hours for the first 5 days and then every 4 hours, until healing has occurred.
Acquired hemophilia - bleeding episodes or surgery:
70 to 90 micrograms/kg by intravenous bolus injection every 2 to 3 hours until hemostasis is achieved.
Usual Adult Dose for Factor VII Deficiency:
Congenital FVII Deficiency - Bleeding Episodes or Surgery:
15 to 30 micrograms/kg every 4 to 6 hours until hemostasis is achieved.
What other drugs will affect coagulation factor VIIa?
Tell your doctor about all other medications you use, especially medications used to treat severe bleeding episodes, such as:
aminocaproic acid (Amicar); or
tranexamic acid (Cyklokapron).
This list is not complete and there may be other drugs that can interact with coagulation factor VIIa. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
More coagulation factor VIIa resources
- Coagulation factor VIIa Side Effects (in more detail)
- Coagulation factor VIIa Dosage
- Coagulation factor VIIa Use in Pregnancy & Breastfeeding
- Coagulation factor VIIa Drug Interactions
- Coagulation factor VIIa Support Group
- 0 Reviews for Coagulation factor VIIa - Add your own review/rating
Compare coagulation factor VIIa with other medications
- Factor VII Deficiency
- Hemophilia A
- Hemophilia B
Where can I get more information?
- Your pharmacist can provide more information about coagulation factor VIIa.
See also: coagulation factor VIIa side effects (in more detail)
No comments:
Post a Comment